| 1 |
2D 1H-15N HSQC |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 2 |
3D HNCACB |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 3 |
3D CBCA(CO)NH |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 4 |
3D HNCO |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 5 |
3D HN(CA)CO |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 6 |
2D 1H-13C HSQC aliphatic |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 7 |
3D C(CO)NH |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 8 |
3D HBHA(CO)NH |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 9 |
3D H(CCO)NH |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 10 |
3D H(C)CH-TOCSY aliphatic |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 11 |
3D 1H-13C NOESY aliphatic |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 12 |
2D 1H-13C HSQC aromatic |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 13 |
3D (HB)CB(CGCD)HE |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 14 |
3D H(C)CH-TOCSY aromatic |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |
| 15 |
3D 1H-13C NOESY aromatic |
1.7 mM [U-100% 13C; U-100% 15N] SARS-CoV-2 nsp7, 10 mM MOPS, 150 mM sodium chloride, 2 mM DTT, 0.025 % sodium azide, 93% H2O/7% D2O |
150 |
93% H2O/7% D2O |
7.0 |
1 |
298 |